Sample | Title | Value | Rank |
GSM1116933 | Synovial tissue prior to Tocilizumab therapy, repl 1 | 0.0063057 | 57 |
GSM1116935 | Synovial tissue prior to Tocilizumab therapy, repl 2 | 0.0842552 | 69 |
GSM1116937 | Synovial tissue prior to Tocilizumab therapy, repl 3 | -0.124673 | 25 |
GSM1116939 | Synovial tissue prior to Tocilizumab therapy, repl 4 | 0.154074 | 76 |
GSM1116941 | Synovial tissue prior to Tocilizumab therapy, repl 5 | 0.027792 | 57 |
GSM1116943 | Synovial tissue prior to Tocilizumab therapy, repl 6 | 0.370749 | 92 |
GSM1116945 | Synovial tissue prior to Tocilizumab therapy, repl 7 | -0.29488 | 18 |
GSM1116947 | Synovial tissue prior to Tocilizumab therapy, repl 8 | 0.229287 | 86 |
GSM1116949 | Synovial tissue prior to Tocilizumab therapy, repl 9 | 0.173206 | 84 |
GSM1116951 | Synovial tissue prior to Tocilizumab therapy, repl 10 | 0.0812359 | 69 |
GSM1116953 | Synovial tissue prior to Tocilizumab therapy, repl 11 | -0.18224 | 19 |
GSM1116955 | Synovial tissue prior to Tocilizumab therapy, repl 12 | -0.0100107 | 45 |
GSM1116934 | Synovial tissue after to Tocilizumab therapy, repl 1 | -0.195515 | 27 |
GSM1116936 | Synovial tissue after to Tocilizumab therapy, repl 2 | 0.508879 | 95 |
GSM1116938 | Synovial tissue after to Tocilizumab therapy, repl 3 | -0.0900478 | 27 |
GSM1116940 | Synovial tissue after to Tocilizumab therapy, repl 4 | -0.177713 | 23 |
GSM1116942 | Synovial tissue after to Tocilizumab therapy, repl 5 | 0.000813 | 56 |
GSM1116944 | Synovial tissue after to Tocilizumab therapy, repl 6 | -0.0108376 | 45 |
GSM1116946 | Synovial tissue after to Tocilizumab therapy, repl 7 | -0.362568 | 9 |
GSM1116948 | Synovial tissue after to Tocilizumab therapy, repl 8 | 0.197496 | 83 |
GSM1116950 | Synovial tissue after to Tocilizumab therapy, repl 9 | 0.312186 | 90 |
GSM1116952 | Synovial tissue after to Tocilizumab therapy, repl 10 | -0.121924 | 24 |
GSM1116954 | Synovial tissue after to Tocilizumab therapy, repl 11 | -3.34e-05 | 50 |
GSM1116956 | Synovial tissue after to Tocilizumab therapy, repl 12 | 3.34e-05 | 50 |